Literature DB >> 27602710

Could Perioperative Opioid Use Increase the Risk of Cancer Progression and Metastases?

Anupam Aich1, Pankaj Gupta, Kalpna Gupta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27602710      PMCID： PMC5061339          DOI： 10.1097/AIA.0000000000000112

Source DB:  PubMed          Journal:  Int Anesthesiol Clin        ISSN： 0020-5907


× No keyword cloud information.
  73 in total

1.  Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.

Authors:  C Gavériaux-Ruff; H W Matthes; J Peluso; B L Kieffer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

2.  Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor β in women undergoing anesthesia and surgery for breast cancer.

Authors:  Micheal Looney; Peter Doran; Donal J Buggy
Journal:  Anesthesiology       Date:  2010-11       Impact factor: 7.892

3.  Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat.

Authors:  B C Yoburn; J Chen; T Huang; C E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  1985-11       Impact factor: 4.030

4.  Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis.

Authors:  Patrick A Singleton; Joe G N Garcia; Jonathan Moss
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

5.  Gene expression profiles of primary breast tumors maintained in distant metastases.

Authors:  Britta Weigelt; Annuska M Glas; Lodewyk F A Wessels; Anke T Witteveen; Johannes L Peterse; Laura J van't Veer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

6.  Mast cell activation contributes to sickle cell pathobiology and pain in mice.

Authors:  Lucile Vincent; Derek Vang; Julia Nguyen; Mihir Gupta; Kathryn Luk; Marna E Ericson; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2013-06-17       Impact factor: 22.113

Review 7.  Involvement of substance P and the NK-1 receptor in cancer progression.

Authors:  Miguel Muñoz; Rafael Coveñas
Journal:  Peptides       Date:  2013-08-07       Impact factor: 3.750

Review 8.  Opioid-induced constipation in chronic noncancer pain.

Authors:  H Christian Weber
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

9.  Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.

Authors:  Susana Garcia-Recio; Gemma Fuster; Patricia Fernandez-Nogueira; Eva M Pastor-Arroyo; So Yeon Park; Cristina Mayordomo; Elisabet Ametller; Mario Mancino; Xavier Gonzalez-Farre; Hege G Russnes; Pablo Engel; Domiziana Costamagna; Pedro L Fernandez; Pedro Gascón; Vanessa Almendro
Journal:  Cancer Res       Date:  2013-09-12       Impact factor: 12.701

10.  Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group.

Authors:  G Apolone; O Corli; A Caraceni; E Negri; S Deandrea; M Montanari; M T Greco
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640
View more
  3 in total

1.  Morpheus and the Underworld-Interventions to Reduce the Risks of Opioid Use After Surgery: ORADEs, Dependence, Cancer Progression, and Anastomotic Leakage.

Authors:  Robert Beaumont Wilson
Journal:  J Gastrointest Surg       Date:  2019-04-01       Impact factor: 3.452

Review 2.  Antitumor Anesthetic Strategy in the Perioperatory Period of the Oncological Patient: A Review.

Authors:  Sonia Santander Ballestín; Andrea Lanuza Bardaji; Cristina Marco Continente; María José Luesma Bartolomé
Journal:  Front Med (Lausanne)       Date:  2022-02-18

3.  Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control.

Authors:  Claudya Morin; Yamini Patel; Munazza Javid; Sarah E Tevis; Thais Fortes; Peter Flom; Charusheela Andaz; Donna-Marie Manasseh; Patrick Borgen; Kristin E Rojas
Journal:  Ann Surg Oncol       Date:  2021-06-02       Impact factor: 5.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.